A clinical trial to study the Effect of Helicobacter pylori bacterial infection removal therapy on the patients of Rheumatoid Arthritis (joint pain).
- Registration Number
- CTRI/2010/091/002808
- Lead Sponsor
- KP Salve Institute of Medical Sciences & Research Centre and Lata Mangeshkar Hospital for the trial.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 59
Inclusion Criteria:
1.Patients of either sex, between 18-65 years of age.
2.Clinically diagnosed Rheumatoid Arthritis patient by American Rheumatism Association, 1987 revised criteria for Classification of Rheumatoid Arthritis.
3.Patient willing for C14-Urea Breath Test (using Heliprobe system of Kibion, Sweden).
Exclusion Criteria
1.Patients with history of Ischemic Heart Disease, Gastro-intestinal tract surgery.
2.Patients with history of Surgical Synovectomy.
3.Known patients with duodenal or gastric ulcer or carcinoma stomach.
Pregnancy.
4.Patients with severe cardio-pulmonary disease, chronic renal failure or presence of joint destruction suggesting a serious disease.
Withdrawal Criteria
1.Subjects were to be withdrawn from the study for the following reasons:
2.At the request of the subject.
3.The investigators consider that a subject?s health was compromised because of an adverse effects or experience or concomitant illness that develops after entering the study.
4.Patient not tolerating Lactitol and Lactic acid bacillus therapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method